XML 124 R107.htm IDEA: XBRL DOCUMENT v3.25.3
Business Segments and Geographic Information - Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 27, 2025
Sep. 28, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]        
Revenues   $ 4,100.5 $ 4,030.3 $ 4,030.4
Cost of goods and services sold   1,599.4 1,571.4 1,549.1
Research and development   245.8 262.7 292.6
Sales and marketing   603.8 585.3 595.3
General and administrative   413.9 400.7 386.2
Cost of revenue adjustments   23.3 11.4 24.6
Amortization of acquired intangible assets   190.9 209.7 233.8
Impairment of intangible assets and equipment   225.9 44.8 223.8
Loss on assets held-for-sale   0.0 0.0 51.7
Restructuring, integration and acquisition-related charges   76.0 51.7 14.1
Contingent consideration – fair value adjustments $ (14.9) 0.0 (1.7) 14.9
Other operating expense adjustments   7.2 10.0 5.7
Operating Income (Loss)   714.3 882.6 668.4
Interest expense, net   (42.7) (13.4) 9.4
Foreign currency and other non-operating income, net   9.6 (4.1) (1.7)
Income before income taxes   681.2 865.1 676.1
Depreciation, amortization and accretion   299.8 309.0 323.4
Capital expenditures   137.0 130.2 150.2
Assets 9,139.3 9,014.9 9,156.0 9,139.3
Diagnostics        
Segment Reporting Information [Line Items]        
Revenues   1,827.2 1,782.0 1,880.1
Cost of goods and services sold   689.6    
Research and development   126.7    
Sales and marketing   228.8    
General and administrative   182.2    
Operating Income (Loss)   599.9    
Breast Health        
Segment Reporting Information [Line Items]        
Revenues   1,484.1 1,522.9 1,432.7
Cost of goods and services sold   611.2    
Research and development   84.5    
Sales and marketing   198.5    
General and administrative   153.1    
Operating Income (Loss)   436.8    
GYN Surgical        
Segment Reporting Information [Line Items]        
Revenues   679.8 641.3 604.2
Cost of goods and services sold   208.3    
Research and development   31.9    
Sales and marketing   167.1    
General and administrative   67.9    
Operating Income (Loss)   204.6    
Skeletal Health        
Segment Reporting Information [Line Items]        
Revenues   109.4 84.1 113.4
Cost of goods and services sold   90.3    
Research and development   2.7    
Sales and marketing   9.4    
General and administrative   10.7    
Operating Income (Loss)   (3.7)    
Operating Segments        
Segment Reporting Information [Line Items]        
Operating Income (Loss)   1,237.6 1,210.2 1,207.2
Operating Segments | Diagnostics        
Segment Reporting Information [Line Items]        
Revenues     1,782.0 1,880.1
Cost of goods and services sold     700.2 699.1
Research and development     151.0 157.1
Sales and marketing     239.1 248.6
General and administrative     182.2 177.5
Operating Income (Loss)     509.5 597.8
Depreciation, amortization and accretion   199.4 218.8 224.7
Capital expenditures   86.7 80.2 85.2
Assets 2,596.4 2,244.0 2,431.3 2,596.4
Operating Segments | Breast Health        
Segment Reporting Information [Line Items]        
Revenues     1,522.9 1,432.7
Cost of goods and services sold     631.1 609.0
Research and development     79.4 95.0
Sales and marketing     191.7 193.0
General and administrative     144.0 142.2
Operating Income (Loss)     476.7 393.5
Depreciation, amortization and accretion   51.3 41.6 50.0
Capital expenditures   19.9 30.9 41.1
Assets 1,170.1 1,531.3 1,588.9 1,170.1
Operating Segments | GYN Surgical        
Segment Reporting Information [Line Items]        
Revenues     641.3 604.2
Cost of goods and services sold     179.5 164.2
Research and development     28.9 35.5
Sales and marketing     144.7 144.6
General and administrative     63.7 56.8
Operating Income (Loss)     224.5 203.1
Depreciation, amortization and accretion   48.2 48.1 48.0
Capital expenditures   25.1 16.6 17.0
Assets 1,455.4 1,644.9 1,419.9 1,455.4
Operating Segments | Skeletal Health        
Segment Reporting Information [Line Items]        
Revenues     84.1 113.4
Cost of goods and services sold     60.6 76.8
Research and development     3.4 5.0
Sales and marketing     9.8 9.1
General and administrative     10.8 9.7
Operating Income (Loss)     (0.5) 12.8
Depreciation, amortization and accretion   0.9 0.5 0.7
Capital expenditures   0.4 1.4 0.8
Assets 33.7 31.2 48.3 33.7
Corporate        
Segment Reporting Information [Line Items]        
Depreciation, amortization and accretion   0.0   0.0
Capital expenditures   4.9   6.1
Assets $ 3,883.7 $ 3,563.5   $ 3,883.7
Corporate | Skeletal Health        
Segment Reporting Information [Line Items]        
Depreciation, amortization and accretion     0.0  
Capital expenditures     1.1  
Assets     $ 3,667.6